Some Patients On Ozempic-Style Drugs Eating Far Too Little, Study Finds

(© Mohammed – stock.adobe.com)

Losing the urge to eat sounds like the perfect side effect for anyone who has battled hunger for years. In a small study from England, though, one woman taking Mounjaro averaged just 541 calories a day, and two other patients also ate under 800.

Published in BMJ Nutrition, Prevention & Health, the research studied 14 adults at a single NHS family doctor’s practice in Northamptonshire. Twelve took Mounjaro (tirzepatide), and two took semaglutide, sold as Wegovy or Rybelsus. Both drugs curb appetite, a big reason they work for weight loss. Protein intake looked healthy, but fiber, vitamin D and iron often fell short of recommended levels.

Patients who have weight-loss surgery get nutrition screening and dietitian follow-up, the authors note, but no equivalent monitoring system exists for these drugs.

Weight-Loss Drug Patients Typically Ate Barely Over Half the Calories They Needed
Researchers invited all 97 patients at Brackley Medical Centre who had been prescribed one of these drugs within the previous year. Seventeen agreed, and 14 finished: 11 women and 3 men, ages 27 to 73. Ten paid for the drugs privately, while four received them through the NHS, Britain’s public health system, three of them with type 2 diabetes. Patients with eating disorders or other conditions likely to significantly affect intake were excluded.

Participants logged meals in a food-tracking app called myfood24 for one to 10 days, typically three, and the main analysis used each person’s first two days. Intake was compared with official UK nutrition targets. Phone interviews of about 20 minutes covered experiences on the medication, changes in eating and support received. The authors called the work a service evaluation meant to generate questions for larger studies, not to prove the drugs cause nutrient gaps.

Typical daily intake was 1,231 calories, 58.5% of estimated needs. Eight of 14 participants ate less than two-thirds of their estimated requirement, and intake ranged from 541 to 2,312 calories. Three averaged under 800, a level at which multiple vitamin and mineral deficiencies become likely, according to research the authors cite. UK guidance says meal-replacement diets of 800 to 1,200 calories should happen only with specialist support, using nutritionally complete products. All three were eating self-selected diets without equivalent oversight, though one was enrolled in a structured support program.

Most Participants on Weight-Loss Drugs Fell Short on Fiber and Vitamin D
Protein was the exception. Typical intake ran about one and a half times the recommended amount, and only one person fell short. Fiber was the biggest nutrient gap, with 12 of 14 participants below two-thirds of the target, followed by vitamin D at 11 of 14. Iron fell short for half of the group. Vitamin D was counted from food only, not sunlight, which also supplies it. Researchers measured food intake rather than blood levels, so the gaps do not confirm diagnosed deficiencies.

Eight participants fell short on at least three of six priority nutrients: fiber, iron, vitamin D, potassium, magnesium and protein. The woman eating 541 calories missed all six. Three others missed five, and all three averaged about 830 calories or fewer. One of them, at 677.5 calories, drew more than 84% of her energy from ultra-processed foods. Another participant, at 1,421 calories, still missed four nutrients, so eating a moderate amount does not guarantee good nutrition. Fruit and vegetable intake fell below the recommended 400 grams a day, about five servings, in six of those eight. Most described home cooking or health-conscious choices, yet still fell short because they were eating so little overall.

Many Weight-Loss Drug Patients Reported Little Medical or Dietary Follow-Up
Interviews added a human side. Two participants expressed “shock” at how little they were eating, something they had not realized until completing the food diary. Others described reduced “food noise,” the constant mental chatter about eating, and called the drug a “turning point” or “game changer,” citing less pain, easier movement and renewed hope. Still, some avoided social meals because of nausea, and others feared regaining weight if they stopped the drug.

Support, though, was thin. Only a handful of participants were in structured programs offering personalized diet guidance and access to the prescriber. Many described a lack of structured NHS follow-up, and inadequate medication reviews left side effects such as dizziness and low blood pressure unmanaged, so some turned to online peer groups.

Source: https://studyfinds.com/ozempic-style-drugs-eating-too-little/

Exit mobile version